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reversible stages of frailty on CVD risk is unknown.
OBJECTIVES This study sought to ascertain whether pre-frailty can predict the onset of CVD in a cohort of community-
dwelling, not disabled, elderly people.
METHODS A sample of 1,567 participants age 65 to 96 years without frailty or disability at baseline was followed for
4.4 years. Pre-frailty was deﬁned as the presence of 1 or 2 modiﬁed Fried criteria (unintentional weight loss, low physical
activity level, weakness, exhaustion, and slow gait speed), and incident CVD as onset of coronary artery diseases, heart
failure, stroke, peripheral artery disease, or CVD-related mortality.
RESULTS During follow-up, 551 participants developed CVD. Compared with participants who did not become frail,
those with 1 modiﬁed Fried criterion (p ¼ 0.03) and those with 2 criteria (p ¼ 0.001) had a signiﬁcantly higher risk of
CVD, even after adjusting for several potential confounders (traditional risk factors for CVD, inﬂammatory markers, and
hemoglobin A1c levels). Low energy expenditure (p ¼ 0.03), exhaustion (p ¼ 0.01), and slow gait speed (p ¼ 0.03) were
signiﬁcantly associated with the onset of CVD, whereas unintentional weight loss and weakness were not.
CONCLUSIONS Our ﬁndings suggest that pre-frailty, which is potentially reversible, is independently associated with a
higher risk of older adults developing CVD. Among the physical domains of pre-frailty, low gait speed seems to be the best
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AB BR E V I A T I O N S
AND ACRONYM S
ABI = ankle-brachial index
BMI = body mass index
BP = blood pressure
CI = conﬁdence interval
CVD = cardiovascular disease
GDS = Geriatric
Depression Scale
HF = heart failure
HR = hazard ratio
myocardial infarction
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977found instrumental in reﬁning their prognosis and
deﬁning optimal care and treatment for elderly indi-
viduals (10).
Several metabolic and hormonal factors, some of
which have also been implicated in the pathogenesis of
CVD (e.g., chronic low-grade inﬂammation and insulin
resistance) (1,2), are responsible for the gradual bio-
logical and functional decline thatmarks the transition
from a state of robustness to pre-frailty and, ulti-
mately, to frailty and its complications (11). It has been
hypothesized that the early detection of a pre-frail
status may provide a window of opportunity for more
aggressive preventive or therapeutic interventions
that might contain disability, hospitalization, and
mortality (12,13). Few and contrasting data are avail-
able, however, on the possible association between
pre-frailty and CVD risk in elderly men and women
without CVD or disability (3,5).SEE PAGE 984The aim of this prospective study is to investigate
the impact of pre-frailty, deﬁned using the 5 modiﬁed
Fried criteria (3) of: 1) unintentional weight loss; 2)
low physical activity level; 3) weakness; 4) exhaus-
tion; and 5) slow gait speed, on the risk of developing
CVD in a cohort of community-dwelling elderly in-
dividuals with no disabilities, CVD, cancer, or de-
mentia at baseline. We adopted a modiﬁed Fried scale
to ascertain pre-frailty because this is the most often
used frailty index (3) and it has consistently been
shown to predict disability and mortality in large co-
horts of elderly patients with and without CVD (4–9).
METHODS
STUDY POPULATION. This study was based on an
analysis of 4.4 1.2 years of follow-up data obtained in
the Progetto Veneto Anziani (Pro.V.A.) population-
based prospective cohort study conducted in 2 sepa-
rate geographic areas near the city of Padua in the
Veneto Region of Northern Italy. The study enrolled
3,099 age- and sex-stratiﬁed community-dwelling in-
dividuals age $65 years (1,854 women and 1,245 men)
from 1995 to 1997. Participants came from a random
sample of white men and women using a multistage
stratiﬁed method described elsewhere (14). After
excluding subjects with a diagnosis of CVD at baseline
(n ¼ 694), subjects with frailty (n ¼ 200) or any
disability in activities of daily living (n ¼ 499), and
subjects who declined to attend follow-up visits (n ¼
139), theﬁnal sample consisted of 1,567 Italian subjects.
At baseline and follow-up examinations, each
participant underwent a detailed structured inter-
view, clinical evaluation, and blood chemistry andperformance-based tests to document an
extensive range of demographic, biological,
and medical characteristics, with the support
of standardized algorithms (14). Cognitive
function was assessed with the 30-item
Mini-Mental State Examination and depres-
sion with the Geriatric Depression Scale
(GDS) (15,16). Face-to-face interviews and
clinical assessments were performed by
trained physicians and nurses. The present
study was approved by the Human Studies
Committee of Padua University and by
the Veneto Region’s Local Health Units
No. 15 and No. 18. All subjects gave their informed
consent.
MEASUREMENTS. Body weight was measured on a
calibrated balance scale. Height was determined us-
ing a stadiometer to the nearest 0.5 cm. Waist
circumference was obtained by using a cloth tape,
with the waist deﬁned as the mid-point between the
highest point of the iliac crest and the lowest part of
the costal margin in the mid-axillary line. Body mass
index (BMI) was calculated as: weight (in kilograms)/
height (in meters) squared. Blood pressure (BP) was
measured with a mercury sphygmomanometer
(Erkameter 300, Erka, Bad Tölz, Germany) in both
arms after the participant had been resting quietly for
>5 min in a seated position. For the ankle-brachial
index (ABI) test, systolic BP was measured with BP
cuffs on the right brachial artery and both posterior
tibial arteries. ABI was calculated as the ratio of the
average ankle systolic to arm systolic BP, taking the
lowest value for reference; a value <0.9 was used for
the diagnosis of peripheral artery disease (17).
Physical performance was assessed as follows:
 Short Physical Performance Battery, derived from 3
objective physical function tests (18). Each test was
scored from 0 (inability to complete the test) to 4
(highest level of performance). The scores from all
3 tests were summarized in a composite score of
0 to 12 with higher scores reﬂecting better physical
function.
1. Tandem test: Participants were asked to main-
tain their balance, progressing from having their
feet side-by-side to a semi-tandem and then
full-tandem position.
2. Gait speed: The best performance achieved in 2
walks at usual pace along a 4-m corridor was
recorded in meters per second. Participants
were allowed to use canes or walkers.
3. Chair stands time: Participants were asked to
stand up and sit down 5 times as quickly as
possible, with their hands folded across their
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978chest. The time taken to complete the test was
recorded in seconds.
 Handgrip strength: Handgrip strength was me-
asured (in kilograms) using a JAMAR hand-held
dynamometer (BK-7498, Fred Sammons, Inc.,
Burr Ridge, Illinois). The best result obtained at 3
attempts on the dominant side was used for our
analyses.
Fried et al. (3) deﬁned frailty using 5 measurable
items. In our study, weakness and slow gait speed
were respectively deﬁned using the best handgrip
strength value and the best timed walk over 4 m at
usual pace, stratiﬁed by sex and BMI cutoffs, as
originally proposed by Fried et al. (3). Fried’s work
had yet to be published when our study was designed
(1995 to 1997), so the other 3 frailty items were
deﬁned slightly differently. In our study, a low en-
ergy expenditure was deﬁned as weekly physical
activity <383 kcal/week in males and <270 kcal/week
in females, calculated from the sum of all the leisure-
time activities performed during an ideal week in the
previous month; unintentional weight loss was
deﬁned as a self-reported unintentional weight loss
>5 kg over the past year; and exhaustion was ascer-
tained by asking the question on the GDS scale, “Do
you feel full of energy?” Participants were considered
exhausted if they gave a negative answer and also
had a GDS score $10, as previously reported (19). A
modiﬁed version of the Fried index was consequently
used in our study.
Participants were classiﬁed as frail if they met 3 or
more of the 5 modiﬁed Fried criteria, as pre-frail if
they met 1 or 2, or as nonfrail if they met none of the
criteria. Subjects unable to perform the handgrip
strength or walking tests were considered as having
weakness or slow gait speed, respectively.
Coronary heart disease was deﬁned as a history of
revascularization, hospitalization for myocardial
infarction (MI), electrocardiographic evidence of MI,
or self-reported history of MI or angina, accompanied
by the use of antianginal medication. Cerebrovascular
disease was deﬁned as a documented (e.g., from
medical charts) history of stroke, transient ischemic
attack, or carotid endarterectomy, conﬁrmed by an in-
depth neurological medical examination. Heart fail-
ure (HF) was deﬁned on the basis of the participants’
history, physical examination, chest radiography, and
use of medication. An HF event was conﬁrmed if, in
addition to a physician’s diagnosis, there were docu-
mented HF signs and symptoms; supporting ﬁndings
(e.g., pulmonary edema on radiograph); or HF
treatments were being used, including diuretics,
digitalis, angiotensin-converting enzyme inhibitors,or beta-blockers. Both at baseline and follow-up, the
physician performing the physical examination
diagnosed any CVD using all the previously listed
measures. Another cardiologist conﬁrmed any CVD
diagnoses using a standardized algorithm considering
all the medical information collected on each partic-
ipant. Any disagreement was resolved by consensus
(14). In the follow-up assessment, CVD mortality
(codes from 390–459 according to International Clas-
siﬁcation of Diseases-9th Revision, 2002) was also
included. A copy of the ofﬁcial death certiﬁcate of all
deceased participants was obtained.
LABORATORY DATA. Blood samples were obtained
after an overnight fast for biochemical tests, which
were performed at the city hospital’s central labora-
tory using standard, quality-control procedures.
Glycated hemoglobin (HbA1c) was measured using
high-performance liquid chromatography. Serum
25-hydroxyvitamin D was measured by radioimmu-
noassay (RIA kit, DiaSorin, Stillwater, Minnesota).
The estimated glomerular ﬁltration rate was calcu-
lated using the Modiﬁcation of Diet in Renal Disease
formula. Total cholesterol, triglycerides, and high-
density lipoprotein cholesterol were calculated
using the enzymatic method. Low-density lipoprotein
cholesterol was calculated with the Friedewald
equation, unless triglycerides were higher than
400 mg/dl. The erythrocyte sedimentation rate was
measured using the Westergren method and sodium
citrate-anticoagulated blood samples.
STATISTICAL ANALYSIS. All measurements obtained
at baseline and follow-up were used in the data anal-
ysis. Participants’ characteristics were summarized
using mean  SD for continuous variables and counts
and percentages for categorical variables. For contin-
uous variables, normal distributions were tested using
the Shapiro-Wilk test. Age- and sex-adjusted p values
for trends were calculated as follows: for continuous
variables the differences between the means of the
covariates by number of frailty criteria were analyzed
using a general linear model; logistic regression was
applied for categorical variables.
The age-standardized incidence of CVD was
calculated as the number of new cases of CVD per
1,000 person-years during follow-up, standardized
according to the age structure of the Italian popula-
tion in 1991, and compared using logistic binary
regression. Cox proportional hazards models were
used to assess associations between participants
meeting 0, 1, or 2 frailty criteria and those with inci-
dent CVD. The time of ﬁrst recorded event was
considered as the “time for event.” Known factors
associated with frailty and/or CVD were considered
TABLE 1 Baseline Characteristics by Pre-Frailty Status (Fried Criteria) in the
PRO.V.A. Study Sample (n ¼ 1,567)
0 Criteria
(n ¼ 867)
1 Criterion
(n ¼ 491)
2 Criteria
(n ¼ 209) p Value*
Age, yrs 71.68  5.55 75.18  6.86 77.77  7.48 <0.0001†
Female 53.4 66.2 77.5 <0.0001†
General characteristics
Current smokers 12.6 7.5 3.3 0.03
Previous smokers 31.8 24.2 18.2 0.69
Alcohol drinkers 76.6 67.6 65.1 0.007
GDS score 8.11  4.25 9.10  4.84 10.60  5.50 <0.0001
MMSE score 25.76  3.78 23.87  5.07 23.04  4.96 <0.0001
SBP, mm Hg 152.22  20.10 153.64  21.44 150.39  18.85 0.04
DBP, mm Hg 84.00  10.31 83.68  11.14 81.71  11.44 0.29
ABI 1.16  0.13 1.12  0.14 1.09  0.14 0.02
Anthropometric characteristics
BMI, kg/m2 27.38  4.13 27.93  4.44 28.44  5.18 <0.0001
Waist circumference, cm 95.51  10.71 95.64  11.21 97.40  14.46 <0.0001
Medical conditions and drugs
Atrial ﬁbrillation 1.9 2.8 3.2 0.07
COPD 4.6 9.0 9.6 <0.0001
Hypertension 67.0 72.7 75.1 0.06
Diabetes 11.6 14.9 14.8 0.23
Use of antihypertensives 54.5 64.1 65.4 0.10
Use of low-dose aspirin 5.2 10.8 6.8 0.37
Use of anticoagulants 0.7 0.9 1.5 0.16
Use of lipid-lowering
drugs
4.1 2.4 1.5 0.08
Biohumoral tests
White blood cells, n/mm3 5.67  1.36 5.84  1.53 6.00  1.60 0.04
ESR, mm/h 16.17  16.40 20.14  17.01 24.77  18.55 0.005
FPG, mmol/l 104.53  30.96 105.58  29.15 105.35  29.46 0.71
HbA1c, % 5.20  0.80 5.30  1.03 5.39  0.98 0.03
25OHD, nmol/l 93.41  55.04 81.15  50.08 75.35  57.22 <0.0001
eGFR, ml/min 72.44  16.26 71.48  18.53 67.66  21.51 0.01
Total cholesterol, mg/dl 235.87  42.20 230.68  42.55 231.05  43.81 0.07
HDL, mg/dl 58.14  17.04 61.74  33.09 61.75  64.46 0.04
Triglycerides, mg/dl 133.56  73.24 129.31  70.82 140.58  85.60 0.21
LDL, mg/dl 153.00  36.56 147.43  37.39 149.98  39.29 0.004
Uric acid, mg/dl 5.07  1.29 5.18  1.47 5.19  1.73 0.04
Values are mean  SD or %. *Unless otherwise speciﬁed, p values are adjusted for age and sex using a general
linear model or logistic regression, as appropriate. †Not adjusted for age or sex, respectively.
25OHD ¼ serum 25-hydroxyvitamin D; ABI ¼ ankle brachial index; BMI ¼ body mass index; COPD ¼ chronic
obstructive pulmonary disease; DBP ¼ diastolic blood pressure; eGFR ¼ estimated glomerular ﬁltration rate;
ESR ¼ erythrocyte sedimentation rate; FPG ¼ fasting plasma glucose; GDS ¼ Geriatric Depression Scale;
HbA1c ¼ glycosylated hemoglobin; HDL ¼ high-density lipoproteins; LDL ¼ low-density lipoproteins;
MMSE ¼ Mini-Mental State Examination; SBP ¼ systolic blood pressure.
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979for inclusion in the analysis. To explore whether a
variable should be included as a predictor in the ﬁnal
survival model, the log-rank test of equality across
strata was performed for all categorical variables, and
Cox univariate proportional hazards regression for all
continuous variables. The predictors included in the
ﬁnal model were all variables reaching a p < 0.20 in
the univariate analyses (Online Table 1). Collinearity
among covariates was quantiﬁed using the variance
inﬂation factor among the covariates. Waist circum-
ference and BMI had a high collinearity (variance
inﬂation factor ¼ 4.58), but waist circumference was
preferred because in older people it seems to be the
best predictor of CVD onset (20). Hazard ratios (HRs)
and 95% conﬁdence intervals (CIs) were used to
compare CVD rates by number of frailty criteria taking
those with 0 criteria for reference. HRs were also
calculated for speciﬁc frailty criteria using the same
covariates as in the ﬁnal model and taking for refer-
ence participants without a given condition. All ana-
lyses were performed using SPSS 21.0 for Windows
(SPSS Inc., Chicago, Illinois). All statistical tests were
two-tailed and statistical signiﬁcance was assumed
for a p value <0.05.
RESULTS
BASELINE CHARACTERISTICS. The sample consisted
of 1,567 elderly subjects (mean age 73.6  6.7 years;
61% were women) with a mean BMI of 27.69 
4.40 kg/m2, with no CVD, frailty, or disability at
baseline. Table 1 shows the baseline characteristics by
pre-frailty criteria according to the number of frailty
criteria met. Pre-frail participants were older and
more frequently women (p for trend <0.0001 for both
variables). After adjusting for age and sex, the vari-
ables of BMI, waist circumference, and GDS score
positively correlated with our modiﬁed Fried frailty
score (Table 1). In contrast, current smoking and sys-
tolic BP were negatively associated with the modiﬁed
Fried frailty score (Table 1). No signiﬁcant differences
in medical conditions were found across the groups,
with the exception of chronic obstructive pulmonary
disease, which was signiﬁcantly higher in the pre-frail
participants (p for trend <0.0001). Compared with
nonfrail participants, those classiﬁed as pre-frail
according to our modiﬁed Fried index had higher
white blood cell counts, erythrocyte sedimentation
rate, HbA1c, uric acid, and high-density lipoprotein
cholesterol levels, but lower ABI, low-density lipo-
protein cholesterol, 25-hydroxyvitamin D levels, and
estimated glomerular ﬁltration rate (Table 1).
FOLLOW-UP DATA. Over a period of 4.4 years, 551 CV
events were recorded (84 participants died of CVD; 27developed severe angina; 36 had acute MI, 249 had
HF, and 8 had stroke; and 147 developed peripheral
artery disease). As shown in Table 2, the age-adjusted
incidence of CVD in the sample as a whole was 75
events per 1,000 person-years (95% CI: 64 to 86), with
a signiﬁcant trend for the incidence of CVD higher in
those meeting 2 frailty criteria (p for trend <0.0001).
Compared with those who did not become frail,
participants meeting 1 criterion were at higher risk
of CVD (HR: 1.25; 95% CI: 1.05 to 1.64), whereas
those meeting 2 criteria were at 80% higher risk of
TABLE 2 Association Between Pre-Frailty Status* and CVD Risk
Number of Criteria
Standardized
Incidence Rate per 1,000
Person-Years
(95% CI)
Unadjusted
Model p Value Model 1 p Value Model 2 p Value Model 3 p Value
0 68 (52–84) 1 [ref.] 1 [ref.] 1 [ref.] 1 [ref.]
1 77 (58–86) 1.51 (1.19–1.92) 0.001 1.23 (1.02–1.59) 0.03 1.18 (0.92–1.53) 0.09 1.25 (1.05–1.64) 0.03
2 99 (92–106) 2.20 (1.65–2.94) <0.0001 1.78 (1.28–2.40) <0.0001 1.64 (1.19–2.27) 0.003 1.79 (1.27–2.52) 0.001
Values are hazard ratio (95% CI) unless otherwise noted. *Pre-frailty status according to number of modiﬁed Fried criteria. Model 1: Adjusted for age and sex. Model 2: Adjusted for the covariates in Model 1
and presence of chronic obstructive pulmonary disease, alcohol drinking, serum 25-hydroxyvitamin D levels, and Geriatric Depression Scale score. Model 3: Adjusted for the covariates in the previous models
and waist circumference, presence of diabetes, hypertension, and atrial ﬁbrillation; use of antihypertensive agents, low-dose aspirin, anticoagulant drugs, and statins; systolic blood pressure, diastolic blood
pressure, and ankle brachial index (as continuous variables); serum high-density lipoproteins, low-density lipoproteins, triglycerides, uric acid, fasting plasma glucose, glycosylated hemoglobin, erythrocyte
sedimentation rate, and white blood cells (as continuous variables); estimated glomerular ﬁltration rate (as a continuous variable); and smoking status.
CI ¼ conﬁdence interval; CVD ¼ cardiovascular disease.
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980experiencing a new CV event (HR: 1.79; 95% CI: 1.27 to
2.52) (Table 2). The higher risk of CV events during
follow-up was conﬁrmed by the cumulative incidence
curve, adjusted for the same covariates as those used
in the ﬁnal Cox model (Figure 1). The other covariates
signiﬁcantly associated with the onset of new CV
events during follow-up were age (HR: 1.05; 95% CI:
1.03 to 1.07; p < 0.0001), GDS (HR: 1.02; 95% CI: 1.002
to 1.05; p ¼ 0.045), and atrial ﬁbrillation (HR: 1.55;
95% CI: 1.03 to 2.91; p ¼ 0.03). The use of low-dose
aspirin was associated with a signiﬁcant reductionive Incidence of Cardiovascular Events
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ber of Fried criteria, the higher the cumulative incidence of cardio-
follow-up. The survival curves are based on adjusted Cox regression
nts according to baseline number of Fried criteria, and the table
er at risk of cardiovascular events according to baseline Fried criteria.in the risk of new CV events (HR: 0.78; 95% CI: 0.52 to
0.96; p ¼ 0.03) (Online Table 2). As shown in Figure 2,
the frailty parameters proving the best predictors of
new CVD events were low energy expenditure (HR:
1.70; 95% CI: 1.07 to 3.50; p ¼ 0.03), exhaustion (HR:
1.53; 95% CI: 1.09 to 2.14; p ¼ 0.01), and slow gait
speed (HR: 1.28; 95% CI: 1.03 to 1.71; p ¼ 0.03),
whereas unintentional weight loss and weakness
were not associated with any signiﬁcantly higher risk
of new cardiovascular events (p ¼ 0.51 and 0.19,
respectively).
DISCUSSION
In our large cohort of community-dwelling elderly
men and women, pre-frailty signiﬁcantly predicted
incident CVD. A 1-U increase in the modiﬁed Fried
score, signifying multisystem decline in physiological
reserves and increased vulnerability to stressors, was
associated with a 25% increased CVD risk. These
ﬁndings were consistent in both sexes and indepen-
dent of known clinical and metabolic risk factors. In
particular, pre-frailty was a signiﬁcant predictor of
incident HF, and more than half of the CVD events
were HF-related. These ﬁndings are consistent with
data from several cross-sectional studies and one
longitudinal study showing that HF is the most
frequent type of CVD in frail and pre-frail elderly in-
dividuals (7,21,22).
The prevalence of pre-frailty in our cohort was
approximately 40% and, as expected, higher in
women and older individuals (23,24). Given that this
population initially had no CVD or disabilities,
this prevalence is extremely high, underscoring the
potential importance of assessing pre-frailty in
apparently healthy elderly men and women. Pre-
frailty has been associated with a 4-fold higher risk
to become frail over a 4-year follow-up (3), so it may
be that this study’s worse outcomes were related to
pre-frail adults transitioning to frail phenotypes
FIGURE 2 Risk of Cardiovascular Events
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Cardiovascular event risk varies by individual Fried criteria (and is
adjusted for the same covariates in Table 2). Unless otherwise
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95% conﬁdence interval (ticks).
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frailty is a reversible clinical condition if treated in
the early stages (3), meaning that such interventions
as cardiac rehabilitation, physical exercise, vitamin D
supplementation, and reducing unnecessary medi-
cation may be able to arrest frailty or delay theCENTRAL ILLUSTRATION Possible Mechanisms and Inter
in the Elderly
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Pre-frailty is associatedwith measures of central adiposity, long-term gluco
(top). Multidimensional assessment is necessary to start beneﬁcial intervetransition from pre-frailty to frailty, and thereby
contain the increase in CVD risk (Central Illustration)
(25–28).
Pre-frailty and frailty have been described as bio-
logical syndromes resulting from the dysregulation of
multiple metabolic pathways (1,11). Consistently, we
found pre-frailty signiﬁcantly associated with mea-
sures of central adiposity, long-term glucose control,
and inﬂammation. The ABI was signiﬁcantly lower in
pre-frail patients too, strongly suggesting early
atherosclerotic disease. Progressively adjusting for
these correlates did not attenuate the association
between pre-frailty and incident CVD, however,
implying that responsibility for the association
between pre-frailty and CVD lies in as-of-yet
unknown factors that need to be identiﬁed. Pre-
frailty may also represent the sum of several nega-
tive conditions and diseases that patients have
accumulated over a lifetime, making them more
sensitive to adverse health outcomes, including CVD.
Interestingly, the prevalence of clinical conditions,
such as depression, chronic obstructive pulmonary
disease, and hypovitaminosis D (thought to play an
independent role in the pathogenesis of CVD [29–31]),
was signiﬁcantly higher in the participants who
became pre-frail. In particular, depression was anventions for Pre-Frailty as Cardiovascular Risk Factor
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se control, and inﬂammation that could promote the onset of cardiovascular disease
ntions early that could slow the progression of cardiovascular disease (bottom).
PERSPECTIVES
COMPETENCY IN PATIENT CARE: Screening
elderly people without overt disability for “pre-frailty”
could identify individuals more likely to harbor car-
diovascular disease.
TRANSLATIONAL OUTLOOK: Clinical trials of in-
terventions targeting the various domains of frailty
are needed to ascertain whether treatment can pre-
vent clinical cardiovascular events.
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982important predictor of incident CVD in our sample,
probably because depression and frailty share the
same metabolic changes (i.e., more inﬂammation and
hypercortisolemia, and an increased adrenergic tone)
that have key roles in the pathogenesis of sarcopenia
and CVD (32). In our study, the risk of developing a
new CV event increased by 2% for each point on the
GDS, reinforcing the importance of diagnosing and
treating depression in elderly men and women at high
risk of CVD (33,34).
Another important ﬁnding of our study was the
relative importance of certain frailty criteria in pre-
dicting CVD events in pre-frail men and women. Low
energy expenditure, exhaustion, and slow gait speed
strongly predicted incident CVD, whereas uninten-
tional weight loss and handgrip strength did not. Our
data are consistent with other studies highlighting
the importance of walking speed as the best predictor
of frailty in patients with prevalent CVD (35). In
contrast with other studies on middle-aged adults
and disabled women (36,37), we failed to ﬁnd any
signiﬁcant association between handgrip strength
and the onset of new CVD. This would support the
conviction that the prognostic importance of physical
performance tests, and frailty criteria in general,
depends on the demographic characteristics of the
population under study and on the outcome being
investigated. In our population, a low gait speed may
be better able than a weak handgrip to reﬂect sys-
temic subclinical CV abnormalities and lesions, such
as an abnormal ABI, left ventricular hypertrophy,
carotid intima-media thickening, and silent carotid
plaques (38,39). Consistent with this idea, it has been
reported that slow gait speed is a powerful predictor
of hospitalization and post-operative morbidity and
mortality in patients with CVD (40,41).
STUDY LIMITATIONS. First, because no imaging was
done to identify subclinical cardiovascular damage,
we cannot rule out the possibility of participants
having a decline in heart function already at baseline.
It is well known that frail subjects could have an
underlying quiescent CVD, such as coronary artery
disease (42). In our sample, however, the presence ofCVD was carefully assessed by highly trained cardi-
ologists (even though no strict deﬁnitions of CVD and
HF were used). A second limitation of our study lies
in that weight loss was self-reported and physical
performance level was investigated using a non-
structural test. Finally, although the interviews were
conducted with the support of relatives, we cannot
exclude the presence of bias.
CONCLUSIONS
We demonstrated a signiﬁcant association between
pre-frailty and the risk of incident CVD (irrespective
of any classical cardiometabolic risk factors). This
suggests that targeting pre-frailty as a potentially
reversible risk factor for CVD in the elderly could have
signiﬁcant implications. Among the physical domains
of pre-frailty, low gait speed seems to be the single
best predictor of future CVD. More studies are war-
ranted to examine the effects of action to treat pre-
frailty or early stages of frailty for the purposes of
preventing CVD.
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